Investigating the effect of a type of vitamin on children's calculus of kidney

Evaluation of the effect of vitamin E therapy on children with Calculus of kidney

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20241126063866N1

Enrollment

100

Registered

2024-12-28

Start date

2024-12-21

Completion date

Unknown

Last updated

2025-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Calculus of kidney. Calculus of kidney

Interventions

Intervention 1: Intervention group: In addition to the standard treatment including hydrochlorothiazide and potassium citrate, vitamin E oral drops, manufactured by Behsa pharmaceutical company intake

Eligibility

Sex/Gender

All

Age

2 Years to 18 Years

Inclusion criteria

Inclusion criteria: 2 to 18 years of age Not consuming vitamin E in the last 2 months Definitive diagnosis of calculus of kidney Consent to participate in the study

Exclusion criteria

Exclusion criteria: Unwillingness to participate in the study Previous allergy to vitamin E

Design outcomes

Primary

Measure	Time frame
Calculus of kidney. Timepoint: Before starting the treatment and at the end of one month treatment. Method of measurement: The number and size of calculus of kidney will be determined based on ultrasound.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHassan Taherahmadi

Arak University of Medical Sciences

Taherahmadi@yahoo.com+98 86 3222 2003

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026